There are 3158 resources available
801MO - Efficacy and safety of a phase II study: Timdarpacept (IMM01) combined with azacitidine (AZA) as the first-line treatment in adults with chronic myelomonocytic leukemia (CMML)
Presenter: Liya Ma
Session: Mini oral session 1: Haematological malignancies
Resources:
Abstract
Slides
Webcast
Resistance and sequencing
Presenter: Mark Awad
Session: Treating KRAS-mutated NSCLC
Resources:
Slides
Webcast
Optimal sequencing of therapeutic strategies in molecularly-driven CRC
Presenter: Lukas Weiss
Session: Metastatic colorectal cancer: Changing paradigms and the relevance for patient care
Resources:
Slides
Webcast
Triple negative breast cancer
Presenter: Giuseppe Curigliano
Session: New treatment algorithm in the treatment of metastatic breast cancer in 2024
Resources:
Slides
Webcast
Novel therapeutic approaches for ARPI-resistant disease
Presenter: Gerhardt Attard
Session: Therapeutic options beyond AR pathway inhibitors: What do we choose next?
Resources:
Slides
Webcast
Summary of clinical trials so far
Presenter: Paolo Ascierto
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
ADCs in endometrial and cervical cancer
Presenter: Toon Van Gorp
Session: Antibody drug conjugates (ADCs): Are there new therapeutic approaches in gynaecological cancers?
Resources:
Slides
Webcast
PK of complex drugs: Strategies to find recommended dosages
Presenter: Neeltje Steeghs
Session: New endpoints in early clinical trials
Resources:
Slides
Webcast
Q&A
Session: Proffered Paper session: Non-metastatic NSCLC
Resources:
Webcast
Socio psychological impact and implementation issues
Presenter: Gareth Evans
Session: Improving the assessment of citizens perception of risk
Resources:
Slides
Webcast